Status:
UNKNOWN
Improving Oesophageal Protection During AF Ablation
Lead Sponsor:
St. George's Hospital, London
Collaborating Sponsors:
Attune Medical
Conditions:
Esophageal Diseases
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Catheter ablation is an established treatment for atrial fibrillation (AF). For those with the more longstanding form of the condition and are graded as longstanding persistent AF, catheter ablation t...
Detailed Description
Overall design This is a randomized controlled trial with 1:1 randomization to study or control group. Treatment/intervention plan and rationale AF patients awaiting to have a planned catheter ablati...
Eligibility Criteria
Inclusion
- • Any AF patient planned for a catheter ablation procedure or a left atrial ablation protocol that puts them at risk of surrounding structural trauma, including oesophageal injury.
Exclusion
- Patients at the age extremities will not be approached for the study. (Paediatric patients or young adults (\<aged 18) or older adults over the age of 85)
- Patients having simple or non-left atrial ablation procedures not needing oesophageal protection.
- Patients at high risk of oesophageal bleeding e.g. oesophageal varices.
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2020
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT03819946
Start Date
February 1 2019
End Date
February 1 2020
Last Update
January 2 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St.George's Hospital
London, United Kingdom, SW170QT